A pilot study to assess feasibility of value based pricing in Cyprus through pharmacoeconomic modelling and assessment of its operational framework: sorafenib for second line renal cell cancer

Overview of attention for article published in Cost Effectiveness and Resource Allocation, May 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy: 1 policy source

twitter: 7 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 55 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform

Cited by World Health Organization on 26 Mar 2018

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.